EMA — authorised 31 December 2009
- Application: EMEA/H/C/000696
- Marketing authorisation holder: ISTA Pharma Limited
- Local brand name: Vitragan
- Status: withdrawn
🇪🇺 SC HYLENEX and Ceftriaxone in European Union
EMA authorised SC HYLENEX and Ceftriaxone on 31 December 2009
Marketing authorisation
SC HYLENEX and Ceftriaxone in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is SC HYLENEX and Ceftriaxone approved in European Union?
Yes. EMA authorised it on 31 December 2009.
Who is the marketing authorisation holder for SC HYLENEX and Ceftriaxone in European Union?
ISTA Pharma Limited holds the EU marketing authorisation.